Integrative-omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
Background Clear cell renal cell carcinoma (ccRCC) is the dominant subtype of renal
cancer. With currently available therapies, cure of advanced and metastatic ccRCC is …
cancer. With currently available therapies, cure of advanced and metastatic ccRCC is …
Circularly permuted variants of two CG-specific prokaryotic DNA methyltransferases
The highly similar prokaryotic DNA (cytosine-5) methyltransferases (C5-MTases) M. MpeI
and M. SssI share the specificity of eukaryotic C5-MTases (5'-CG), and can be useful …
and M. SssI share the specificity of eukaryotic C5-MTases (5'-CG), and can be useful …